Literature DB >> 2403644

Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation.

S R Sloan1, E W Newcomb, A Pellicer.   

Abstract

Neutron radiation is known to produce tumors in animals and cause cell transformation. We have developed a protocol to efficiently induce thymic lymphomas in RF/J mice by a single acute dose of neutron irradiation. Activated ras genes were detected in 17% (4 of 24) of the tumors analyzed. One of the tumors contained a K-ras gene activated by a point mutation in codon 146. Activating ras mutations at position 146 have not been previously detected in any known human or animal tumors. The spectrum of ras mutations detected in neutron radiation-induced thymic lymphomas was different from that seen in thymic lymphomas induced by gamma radiation in the same strain of mice. These results may have important implications for the mechanisms by which different types of radiation damage DNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403644      PMCID: PMC360767          DOI: 10.1128/mcb.10.1.405-408.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  24 in total

1.  The influence of dose and dose rate on the incidence of neoplastic disease in RFM mice after neutron irradiation.

Authors:  R L Ullrich; M C Jernigan; G E Cosgrove; L C Satterfield; N D Bowles; J B Storer
Journal:  Radiat Res       Date:  1976-10       Impact factor: 2.841

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

Review 3.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

Review 4.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Neoplastic transformation is enhanced by multiple low doses of fission-spectrum neutrons.

Authors:  C K Hill; B A Carnes; A Han; M M Elkind
Journal:  Radiat Res       Date:  1985-06       Impact factor: 2.841

6.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.

Authors:  J L Bos; D Toksoz; C J Marshall; M Verlaan-de Vries; G H Veeneman; A J van der Eb; J H van Boom; J W Janssen; A C Steenvoorden
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

Review 7.  N-ras and human cancer.

Authors:  I A McKay; H Paterson; R Brown; D Toksoz; C J Marshall; A Hall
Journal:  Anticancer Res       Date:  1986 May-Jun       Impact factor: 2.480

8.  Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment.

Authors:  S H Reynolds; S J Stowers; R M Patterson; R R Maronpot; S A Aaronson; M W Anderson
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

9.  Biochemistry of DNA lesions.

Authors:  J F Ward
Journal:  Radiat Res Suppl       Date:  1985

10.  Genetically determined resistance to 3-methylcholanthrene-induced lymphoma is expressed at the level of bone marrow-derived cells.

Authors:  S T Ishizaka; F Lilly
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Chromosomal changes: radiation sensitive sites on chromosome 2 and their role in radiation myeloid leukaemogenesis in the mouse.

Authors:  R Cox; G Breckon; A R Silver; W K Masson; A M George
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

2.  Recurrent KRAS codon 146 mutations in human colorectal cancer.

Authors:  Sarah Edkins; Sarah O'Meara; Adrian Parker; Claire Stevens; Marcelo Reis; Siân Jones; Chris Greenman; Helen Davies; Gillian Dalgliesh; Simon Forbes; Chris Hunter; Raffaella Smith; Philip Stephens; Peter Goldstraw; Andrew Nicholson; Tsun Leung Chan; Victor E Velculescu; Siu Tsan Yuen; Suet Yi Leung; Michael R Stratton; P Andrew Futreal
Journal:  Cancer Biol Ther       Date:  2006-08-01       Impact factor: 4.742

3.  A novel point mutation at codon 146 of the K-ras gene in a human colorectal cancer identified by the polymerase chain reaction.

Authors:  S Orita; T Higashi; Y Kawasaki; A Harada; H Igarashi; T Monden; H Morimoto; T Shimano; T Mori; J Miyoshi
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

4.  Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors.

Authors:  Atsuo T Sasaki; Arkaitz Carracedo; Jason W Locasale; Dimitrios Anastasiou; Koh Takeuchi; Emily Rose Kahoud; Sasson Haviv; John M Asara; Pier Paolo Pandolfi; Lewis C Cantley
Journal:  Sci Signal       Date:  2011-03-08       Impact factor: 8.192

5.  High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.

Authors:  Jeffrey W Tyner; Heidi Erickson; Michael W N Deininger; Stephanie G Willis; Christopher A Eide; Ross L Levine; Michael C Heinrich; Norbert Gattermann; D Gary Gilliland; Brian J Druker; Marc M Loriaux
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

6.  Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine.

Authors:  G Smith; R Bounds; H Wolf; R J C Steele; F A Carey; C R Wolf
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

7.  Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.

Authors:  Chih-Chieh Chen; Tze-Kiong Er; Yen-Yi Liu; Jenn-Kang Hwang; Maria Jesus Barrio; Maximiliano Rodrigo; Enrique Garcia-Toro; Marta Herreros-Villanueva
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Authors:  Ya-Sian Chang; Kun-Tu Yeh; Tien-Jye Chang; Connie Chai; Hsiu-Chin Lu; Nicholas C Hsu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2009-06-11       Impact factor: 4.430

9.  The impact of KRAS mutations on VEGF-A production and tumour vascular network.

Authors:  Agnès Figueras; Maria Antonia Arbos; Maria Teresa Quiles; Francesc Viñals; Josep Ramón Germà; Gabriel Capellà
Journal:  BMC Cancer       Date:  2013-03-18       Impact factor: 4.430

Review 10.  ras activation in human tumors and in animal model systems.

Authors:  M Corominas; S R Sloan; J Leon; H Kamino; E W Newcomb; A Pellicer
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.